Head-to-head · WeighScore
RxSpan MD vs WePeptideRx
By GLP-1 ScorecardUpdated
Score comparison
RxSpan MD has the higher recorded score — 84.3/100 to 61.4/100.
RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.
Before you choose
RxSpan MD does not publish a semaglutide price, so its RxSpan MD review sets out what it does disclose, while the WePeptideRx review explains the conditions attached to WePeptideRx's figure. The semaglutide cost page compares published rates across the field. Ask RxSpan MD for a written total before treating either one as the cheaper choice.
If neither one fits, 9amHealth vs RxSpan MD and The Edit vs WePeptideRx compare each of them with another graded program, and the list of alternatives to RxSpan MD ranks the programs closest to RxSpan MD on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | RxSpan MD | WePeptideRx |
|---|---|---|
| WeighScore | 84.3/100 | 61.4/100 |
| Grade | B | C |
| Site position | #4 | #321 |
| Semaglutide | Current compounded quote unconfirmed | From $149 per 30-day supply (advertised discount, compounded) |
| Tirzepatide | Current compounded quote unconfirmed | From $159 per 30-day supply (advertised discount, compounded) |
| Coverage | Confirm treatment availability during intake | Coverage varies by treatment and state |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #4 · B
Strengths
- Current public catalog lists Ozempic, Wegovy, Mounjaro and Zepbound
- Public terms describe independent healthcare providers
- Homepage describes messaging and care-team appointments
What to consider
- Homepage advertises compounded plans that the current catalog did not substantiate
- Current oral GLP-1 availability is unconfirmed
- Prior compounded prices are not a current quote; selected dose, supply, pharmacy and fee inclusions need confirmation
- Public terms do not establish unused prepaid-treatment refund amounts
Strengths
- Lists compounded and brand-name treatment options
- Advertises consultation and shipping in the treatment price
- Publishes a refund process for clinically declined items
What to consider
- Charges at checkout before clinical review
- The public discount does not establish the next bill
- Medication refunds are unavailable after dispensing and shipping
Featured provider
RxSpan MD
RxSpan MD scores 84.3/100 (B). RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.